12 February 2020
Dr Damian Roland explains why innovation is one of the four major workstreams we are considering in our Paediatrics 2040 project.
19 August 2019
The Prime Minister has today called for urgent action to boost the number of children and young people receiving life-saving vaccinations. This comes as it is revealed that the UK has lost its "measles-free" status with the WHO, three years after it had eliminated the virus.
29 June 2019
We believe that child health research should be embedded as part of every paediatrician’s training, and throughout their careers. From June 2019 to 10 January 2020, we invited paediatricians working as consultants, SAS doctors and/or CCT holders to complete 2019 Participation in Child Health Researc...
17 May 2019
RCPCH's immunisation expert Dr David Elliman says "compulsion may work in some countries, but it is not for us".
9 April 2019
Boys aged 12-13 in Northern Ireland are to be offered a vaccine to protect them against Human Papillomavirus (HPV) related cancers, the Department of Health has announced. RCPCH responds.
27 March 2019
The RCPCH highly recommends vaccination and that anyone who has concerns or questions talk to their health visitor, practice nurse or general practitioner (GP).
20 February 2019
The Nuffield Trust and the Association for Young People's Health have today published the first ever international comparison of young people's health measures over time, comparing the UK to 18 other high-income countries. Professor Russell Viner, President of the RCPCH, responds.
8 November 2018
We have started work on our two-year project of enquiry, which will set a vision for the future of paediatrics in the UK.
25 October 2018
In a guest blog anticipating the start of 'flu season, RCPCH immunisation experts, Professor Helen Bedford and Dr David Elliman share their thoughts on improving rates of vaccination among children, some misconceptions around the flu vaccination and the role of the paediatrician.
22 August 2018
Professor Helen Bedford stresses the importance of the Measles, Mumps and Rubella (MMR) vaccine in response to news that measles rates in Europe have hit a record high in this decade.